Merit Financial Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.72M Sell
110,651
-4,690
-4% -$210K 0.03% 449
2026
Q1
$5.56M Buy
115,341
+21,973
+24% +$1.02M 0.04% 359
2025
Q4
$4.52M Sell
93,368
-1,337
-1% -$66.3K 0.04% 380
2025
Q3
$4.47M Buy
94,705
+4,250
+5% +$205K 0.04% 338
2025
Q2
$4.37M Buy
90,455
+62,607
+225% +$3.2M 0.05% 308
2025
Q1
$1.54M Buy
27,848
+7,054
+34% +$382K 0.02% 505
2024
Q4
$1M Sell
20,794
-502
-2% -$25.5K 0.02% 509
2024
Q3
$1.23M Sell
21,296
-1,558
-7% -$84.1K 0.03% 372
2024
Q2
$1.11M Sell
22,854
-238
-1% -$11.5K 0.02% 380
2024
Q1
$1.13M Buy
23,092
+17,953
+349% +$877K 0.03% 370
2023
Q4
$256K Buy
+5,139
New +$251K 0.01% 664

Other funds holding SNY

Merit Financial Group's SNY Position: Q2 2026 in Review

Merit Financial Group reduced its Sanofi (SNY) stake by 4.1% in Q2 2026, selling an estimated $210K and leaving 110,651 shares worth $4.72M. The position accounts for 0.03% of the portfolio, ranked #449.

Merit Financial Group first reported a position in SNY in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.56M in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Merit Financial Group held 110,651 shares of Sanofi worth $4.72M as of Q2 2026.
  • Merit Financial Group sold 4,690 Sanofi shares in Q2 2026, an estimated $210K.
  • Sanofi made up 0.03% of Merit Financial Group's portfolio in Q2 2026, its #449 holding.
  • Merit Financial Group first reported a position in Sanofi in Q4 2023 and has held it in 11 quarters since.
  • Merit Financial Group's Sanofi position peaked at $5.56M in Q1 2026.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.